All Articles

HDI Global's appointment of Dan Feige isn't just a new hire; it's a strategic shot across the bow in the competitive US specialty insurance market.

The financial giant extends its massive Security and Resiliency Initiative north, targeting defense, energy, and supply chains to bolster regional stability.

Pacer ETFs slashes fees and expands its Swan SOS series, intensifying competition in the $92 billion buffer ETF market for risk-conscious investors.

As AI's power demands threaten to overwhelm the grid, Maase Inc.'s Huazhi Future is betting on 800VDC. A deep dive into the tech that could redefine data centers.

Sumitomo Pharma's new data reveals a potent combination therapy for myelofibrosis and decodes resistance in leukemia, shaking up a competitive oncology landscape.

For 11 years, CBTS has made CRN's elite list. We unpack how their full-stack strategy and focus on AI are redefining resilience for modern enterprises.

A deep dive into Momentive Software's new partner ecosystem, a strategic bet that human expertise, not just AI, is the key to unlocking the nonprofit sector.

A new precision drug, ART5803, is offering hope for a devastating brain disorder. Arialys Therapeutics is fast-tracking its development with key clinical trials.

A new strategic alliance between a pharma giant and a leading non-profit is deploying a $20M plan to close the deadly prostate cancer survival gap.

As mid-year burnout and remote work disconnection threaten productivity, a new model emerges that replaces passive perks with high-tech, high-impact experiences.

After a $40 billion market collapse, venture capital is back with a new playbook. Anterra Capital’s new fund signals a shift from hype to real-world AI.

1Password's strategic purchase of Apono aims to solve the identity crisis of the AI era, offering a unified platform for human and machine access.

With a $50M seed round, Radical Numerics aims to build general biological intelligence, walking a fine line between curing disease and creating bioweapons.

A US food-tech innovator and a Bulgarian industrial giant are quadrupling animal-free egg protein production, signaling a tectonic shift in global supply chains.

From luxury jewelry to aerospace alloys, the machinery behind precious metals is evolving. A Chinese tech company is now leading a global charge.

The MET airport opens with promises of economic revival and smoother travel, but its true test lies in balancing private ambition with the public good.

As Orca Bio builds a manufacturing empire from Sacramento to Princeton, it's not just preparing for a new drug launch—it's trying to solve the biggest puzzle in biotech.

BVI's new European training hub isn't just a facility; it's a response to a critical skills gap in medicine, revealing how industry is shaping our trust in healthcare.

A new national awards program from She and Success Business Magazine seeks to elevate Canadian women entrepreneurs, addressing a critical need for recognition.

CEO Emun Zabihi’s EY award isn’t just a personal victory. It’s a signal that iHerb has perfected the digital and physical infrastructure for global wellness.